鼻咽癌是一种起源于鼻咽上皮的恶性肿瘤，因其位置隐蔽且早期症状不明显，大多数患者在就医时已发生淋巴结转移。复发和转移是导致鼻咽癌治疗效果不佳的主要原因。鼻咽癌的发生与发展涉及多种癌基因与肿瘤抑制基因的异常表达，但其具体发病机制尚未完全阐明。环状RNA（circular RNA, ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

The company launched its first product, MindLight, in September 2024. MindLight uses the company’s circular-RNA (circRNA) platform to predict the patients who are more likely to respond to the ...

Altamira will start offering its platform to biotech and pharma companies for use with circular RNA under the CycloPhore™ label, complementing its offerings for siRNA (OligoPhore™) and mRNA ...

The collaboration licenses Emervax to use Kindeva’s microneedle array patch to administer vaccines developed using its RNA platform.

Kindeva and Emervax partner to develop painless vaccine delivery technology, targeting viruses like Yellow Fever, Ebola, and ...

Further proof of great versatility of Altamira’s platform for extrahepatic RNA delivery Circular mRNA significantly increasing protein expression vs. linear mRNA Filed provisional patent application, ...

Circio Holding ASA, a biotechnology company developing circular RNA technology for next-generation nucleic acid medicine, has ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Circio Holding ASA is advancing its innovative circular RNA technology, aiming to revolutionize nucleic acid ...

Orna Therapeutics and Shanghai Simnova expand their collaboration to develop RNA-based therapies targeting BCMA for multiple ...

Portal has accumulated over 50 biopharma and academic partners leveraging the platform for applications ranging from novel drug screening assays to engineering cell therapies with circular RNA.